Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05160506
PHASE2

Corticosteroids to Treat Pancreatitis

Sponsor: Beth Israel Deaconess Medical Center

View on ClinicalTrials.gov

Summary

This research is being done to determine if the administration of a short course of intravenous hydrocortisone, an anti-inflammatory medication, to patients with severe acute pancreatitis will improve their clinical outcomes and decrease the length of hospitalization. We think that because inflammation in the body drives the progression of pancreatitis, giving a short course of intravenous hydrocortisone may mitigate disease progression and improve clinical outcomes in patients with severe acute pancreatitis.

Official title: Corticosteroids to Reduce Inflammation in Severe Pancreatitis: A Randomized, Controlled Study

Key Details

Gender

All

Age Range

18 Years - 99 Years

Study Type

INTERVENTIONAL

Enrollment

86

Start Date

2022-03-06

Completion Date

2027-04

Last Updated

2026-02-18

Healthy Volunteers

No

Interventions

DRUG

Hydrocortisone

Hydrocortisone is a steroid (corticosteroid) medication.

DRUG

Placebo

50ml of 0.9% NACL will serve as the placebo

Locations (1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States